All of the evidence provided on Hippocampome.org are quotes from scientific texts.
However, because quoted passages may be difficult to understand in isolation, contextual information and expanded abbreviations set in square brackets have been added for clarity.
Animal:
Protocol:
Expression:
Show:
Order:
EXPRESSION: negative
ANIMAL: rat
PROTOCOL: mRNA
Page location: p613, left bottom
Linking PMID: 1436505 Linking Quote: Principal neurons identified by the presence of their somata in the principal cell layer, which is densely packed with and nearly homogeneous for the somata of the subregion's principal neurons (Czeh et al., 2013, Acta Biologica Hungarica).
"On coronal sections of the rat forebrain at the level
of the dorsal hippocampus the CCK mRNA probe
labeled cells in the cerebral cortex, the thalamus and the pyramidal layer of CA1 of the hippocampus as
well as in scattered neurons throughout the hippocampus (Fig. 2). Hybridization of adjacent sections to
a 4%mer oligonucleotide specific for PPT-A mRNA
revealed intense labeling over cells in the medial
habenular nucleus and caudal parts of caudate-putamen (Fig. 3) while no PPT-A mRNA expressing
cells were detected in the hippocampus."
EXPRESSION: negative
ANIMAL: rat
PROTOCOL: mRNA
Page location: p614, Fig. 3
Linking PMID: 1436505 Linking Quote: Principal neurons identified by the presence of their somata in the principal cell layer, which is densely packed with and nearly homogeneous for the somata of the subregion's principal neurons (Czeh et al., 2013, Acta Biologica Hungarica).
"Fig. 3. PPT-A mRNA expression in the hippocampus after injection of RA. Sections adjacent to those
shown in Fig. 2 were hybridized to an oligonucleotide specific for PPT-A mRNA. Note strong and similar
labeling intensities in all three panels in medial habenuiar nucleus close to midline. Note also the increased
PPT-A mRNA levels in dentate gyrus and CA3 ipsilateral to the kainic acid injections (middle panel).
which is attenuated by dexamethasone treatment (lower panel). "